Transcellular synthesis of Cys-LT: From isolated cells to complex organ system

Advances in Experimental Medicine and Biology

Volumn 433, Issue , 1997, Pages 95-98

  Sala, Angelo ^a   Rossoni, Giuseppe ^a   Berti, Ferruccio ^a   Müller Peddinghaus, Reiner ^a   Folco, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; CALCIMYCIN; LEUKOTRIENE A4; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; PEPTIDOLEUKOTRIENE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL INTERACTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ICOSANOID METABOLISM; ISOLATED HEART; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031391098     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1810-9_19     Document Type: Article

References (11)

1. J. Macouf, R.C. Murphy, and P. Henson. Transcellular sulfidopeptide leukotriene biosynthetic capacity of vascular cells. Blood 74:703 (1989).
2. 4, and not Leukotriene 64, is the main 5-lipoxygenase metabolite released by bovine leukocytes. FEBS Lett. 388: 94 (1996).
3. 4 from human polymorphonuclear leukocytes. J. Biol. Chem. 271: 17944 (1996).
4. 4 synthesized by polymorphonuclear leukocytes. J. Biol. Chem. 261:16466 (1986).
5. 4 by human platelets. J. Biol. Chem. 263:174 (1988).
6. F. Grimminger, B. Kreusler, U. Schneider, G. Decker, and W Seeger. Influence of microvascular adherence on neutrophil leukotriene generation. J. Immunol. 144:1866 (1990).
7. A. Sala, G. Rossoni, C. Buccellati, F. Berti, G.C. Folco, and J. Maclouf. Formation of sulfidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of the rabbit. Br. J. Pharmacol. 110:1206 (1993).
8. Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit. Blood 87:1824 (1996).
9. A. Hatzelmann, R. Fruchtmann, K.H. Mohrs, S. Raddatz, and R. Müller-Peddinghaus. Mode of action of the new selective leukotriene synthesis inhibitor BAY X1005 ((R)-2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentyl acetic acid and structurally related compounds. Biochem. Pharmacol., 45: 101 (1993).
10. C. Haslett, L.A. Guthrie, M.M. Kopaniac, R.B. Johnston, and P.M. Henson. Modulation of multiple neutrophil functions by preparative methods for trace concentrations of bacterial lipolysaccharide. Am. J. Pathol. 119:101 (1985).
11. M. Carry, V. Korley, J.T. Willerson, L. Weigelt, A.W. Ford-Hutchinson, and P. Tagari. Incresed urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Circulation 85:230 (1992).